Co-design and feasibility of an mHealth survivorship program for colorectal cancer survivors: a mix-methods study

PURPOSE: Colorectal cancer (CRC) survivors experience persistent challenges that negatively affect health-related quality of life (HRQoL). While mobile health (mHealth) may offer a useful approach to survivorship care, limited user involvement and scarcity of structured programs in developing countries remain barriers. This study aimed to co-design and evaluate the feasibility of an mHealth survivorship program for CRC survivors following primary treatment. METHODS: A mixed-methods study was conducted in two phases. Phase 1 utilized a user-centered design framework involving 12 co-designers across nine online sessions to develop and refine the FORYOU mHealth program. Phase 2 was a pilot randomized controlled trial (RCT) with 30 CRC survivors to assess feasibility and preliminary effectiveness of the 12-week program, measured by HRQoL outcomes. RESULTS: In phase 1, the co-designed program indicated above-average usability (System Usability Scale ≥ 68) and adequate acceptability (E-Acceptability Scale ≥ 24). In phase 2, the adherence rate was 73.3%; participants in the intervention group completed an average of 5.4 out of 6 sessions and accessed the app 9.7 times. Although no significant between-group difference was observed in overall HRQoL, exploratory findings were mixed. The intervention favored the subscale functional well-being (P < 0.05; g = 1.34), whereas the control group favored the secondary outcome, fatigue. These preliminary findings require cautious interpretation. CONCLUSION: The co-designed mHealth program was usable and acceptable, and the pilot RCT was feasible among CRC survivors after primary treatment. Exploratory findings suggested possible benefits in selected outcomes, but these preliminary findings require confirmation in a larger adequately powered trial. IMPLICATIONS FOR CANCER SURVIVORS: This co-designed mHealth survivorship program showed encouraging engagement among CRC survivors after primary treatment, with exploratory findings suggesting potential effects on selected survivorship outcomes. Trial registration NCT07158671 on ClinicalTrials.gov. Registered on September 8, 2025.

Authors

Institutions

Publication Details

Journal
Journal of Cancer Survivorship
Published
2026-11-18
DOI
https://doi.org/10.1007/s11764-026-02160-9
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Co-design and feasibility of an mHealth survivorship program for colorectal cancer survivors: a mix-methods study

Yuen Tung Lam, Shishuang Zhou, Cho Lee Wong, Quế Trân Nguyễn et al.
3 links
Journal of Cancer Survivorship
Mobile Health and mHealth Applications
article

Co-design and feasibility of an mHealth survivorship program for colorectal cancer survivors: a mix-methods study

Yuen Tung Lam, Shishuang Zhou, Cho Lee Wong, Quế Trân Nguyễn, Pham Nhat Vi Do, Thi Huong Ly Tran, Thi Nhi Vo, Van Kha Vo, Thi Khanh Nguyen
article en

Abstract

PURPOSE: Colorectal cancer (CRC) survivors experience persistent challenges that negatively affect health-related quality of life (HRQoL). While mobile health (mHealth) may offer a useful approach to survivorship care, limited user involvement and scarcity of structured programs in developing countries remain barriers. This study aimed to co-design and evaluate the feasibility of an mHealth survivorship program for CRC survivors following primary treatment. METHODS: A mixed-methods study was conducted in two phases. Phase 1 utilized a user-centered design framework involving 12 co-designers across nine online sessions to develop and refine the FORYOU mHealth program. Phase 2 was a pilot randomized controlled trial (RCT) with 30 CRC survivors to assess feasibility and preliminary effectiveness of the 12-week program, measured by HRQoL outcomes. RESULTS: In phase 1, the co-designed program indicated above-average usability (System Usability Scale ≥ 68) and adequate acceptability (E-Acceptability Scale ≥ 24). In phase 2, the adherence rate was 73.3%; participants in the intervention group completed an average of 5.4 out of 6 sessions and accessed the app 9.7 times. Although no significant between-group difference was observed in overall HRQoL, exploratory findings were mixed. The intervention favored the subscale functional well-being (P < 0.05; g = 1.34), whereas the control group favored the secondary outcome, fatigue. These preliminary findings require cautious interpretation. CONCLUSION: The co-designed mHealth program was usable and acceptable, and the pilot RCT was feasible among CRC survivors after primary treatment. Exploratory findings suggested possible benefits in selected outcomes, but these preliminary findings require confirmation in a larger adequately powered trial. IMPLICATIONS FOR CANCER SURVIVORS: This co-designed mHealth survivorship program showed encouraging engagement among CRC survivors after primary treatment, with exploratory findings suggesting potential effects on selected survivorship outcomes. Trial registration NCT07158671 on ClinicalTrials.gov. Registered on September 8, 2025.

Journal of Cancer Survivorship
Chinese University of Hong Kong (HK), University Medical Center HCMC (VN), Can Tho Oncology Hospital (VN)
Good health and well-being
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon